Oppenheimer Asset Management Inc. Has $756,000 Position in Global X Genomics & Biotechnology ETF $GNOM

Oppenheimer Asset Management Inc. increased its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) by 8.1% during the 2nd quarter, HoldingsChannel reports. The firm owned 89,631 shares of the company’s stock after purchasing an additional 6,708 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Global X Genomics & Biotechnology ETF were worth $756,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC lifted its stake in Global X Genomics & Biotechnology ETF by 182.4% in the 2nd quarter. Halbert Hargrove Global Advisors LLC now owns 13,685 shares of the company’s stock valued at $115,000 after acquiring an additional 8,839 shares in the last quarter. HighTower Advisors LLC raised its stake in Global X Genomics & Biotechnology ETF by 16.7% in the 1st quarter. HighTower Advisors LLC now owns 15,242 shares of the company’s stock valued at $121,000 after acquiring an additional 2,184 shares during the period. Smartleaf Asset Management LLC raised its stake in Global X Genomics & Biotechnology ETF by 18.5% in the 1st quarter. Smartleaf Asset Management LLC now owns 14,933 shares of the company’s stock valued at $125,000 after acquiring an additional 2,329 shares during the period. Oxinas Partners Wealth Management LLC increased its position in Global X Genomics & Biotechnology ETF by 12.1% during the 2nd quarter. Oxinas Partners Wealth Management LLC now owns 16,212 shares of the company’s stock worth $137,000 after buying an additional 1,751 shares during the period. Finally, Private Advisor Group LLC increased its holdings in shares of Global X Genomics & Biotechnology ETF by 14.3% during the first quarter. Private Advisor Group LLC now owns 20,738 shares of the company’s stock worth $165,000 after purchasing an additional 2,587 shares during the period. Institutional investors own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Trading Up 2.2%

Shares of GNOM opened at $45.45 on Friday. Global X Genomics & Biotechnology ETF has a 12 month low of $27.20 and a 12 month high of $45.47. The firm’s 50 day moving average is $39.72 and its 200-day moving average is $35.60. The stock has a market capitalization of $55.45 million, a PE ratio of -19.42 and a beta of 1.22.

Global X Genomics & Biotechnology ETF Company Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.